RINALDI, NICOLA
RINALDI, NICOLA
522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy
2007-01-01 Negri, F.; Musolino, A.; Naldi, N.; Bortesi, B.; Boni, C.; Bisagni, G.; Camisa, R.; Ardizzoni, A.
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes
2005-01-01 Musolino, A.; Naldi, N.; Michiara, M.; Bella, M. A.; Zanelli, P.; Bortesi, B.; Capelletti, M.; Savi, M.; Neri, T. M.; Ardizzoni, A.
Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review
2019-01-01 Militello, A. M.; Zielli, T.; Boggiani, D.; Michiara, M.; Naldi, N.; Bortesi, B.; Zanelli, P.; Uliana, V.; Giuliotti, S.; Musolino, A.
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study
2005-01-01 Musolino, A.; Michiara, M.; Bella, M. A.; Naldi, N.; Zanelli, P.; Bortesi, B.; Capelletti, M.; Soldani, L.; Camisa, R.; Martella, E.; Franciosi, V.; Savi, M.; Neri, T. M.; Ardizzoni, A.; Cascinu, S.
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy
2014-01-01 Negri, F. V.; Musolino, A.; Naldi, N.; Bortesi, B.; Missale, G.; Laccabue, D.; Zerbini, A.; Camisa, R.; Chernyschova, N.; Bisagni, G.; Loupakis, F.; Ruzzo, A.; Neri, T. M.; Ardizzoni, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy | 1-gen-2007 | Negri, F.; Musolino, A.; Naldi, N.; Bortesi, B.; Boni, C.; Bisagni, G.; Camisa, R.; Ardizzoni, A. | |
| A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes | 1-gen-2005 | Musolino, A.; Naldi, N.; Michiara, M.; Bella, M. A.; Zanelli, P.; Bortesi, B.; Capelletti, M.; Savi, M.; Neri, T. M.; Ardizzoni, A. | |
| Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review | 1-gen-2019 | Militello, A. M.; Zielli, T.; Boggiani, D.; Michiara, M.; Naldi, N.; Bortesi, B.; Zanelli, P.; Uliana, V.; Giuliotti, S.; Musolino, A. | |
| Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study | 1-gen-2005 | Musolino, A.; Michiara, M.; Bella, M. A.; Naldi, N.; Zanelli, P.; Bortesi, B.; Capelletti, M.; Soldani, L.; Camisa, R.; Martella, E.; Franciosi, V.; Savi, M.; Neri, T. M.; Ardizzoni, A.; Cascinu, S. | |
| Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy | 1-gen-2014 | Negri, F. V.; Musolino, A.; Naldi, N.; Bortesi, B.; Missale, G.; Laccabue, D.; Zerbini, A.; Camisa, R.; Chernyschova, N.; Bisagni, G.; Loupakis, F.; Ruzzo, A.; Neri, T. M.; Ardizzoni, A. |